Clinical trial
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic…
NCT00473655 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00473655 |
|---|---|
| Title | Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients |
| Official title | A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia, Hyperlipoproteinemia Type IV, Hyperlipoproteinemia Type V, Hyperlipoproteinemia Type IIb, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | rosuvastatin |
| Enrollment | 334 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | May 15, 2007 |
| Last update posted | Dec 16, 2010 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: